Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
McKenna,, Thom, Reddy,, Rouse,, Tolosa,, Saadé Saadé, Rouse, Casey,, Gibbs,, Thorp, Norton,, Chien,, Caritis,, Swamy, Sorokin,, Blackwell,, Tita,, Thorp,, Peaceman,, Clark,, Jain,
2020Carolina Digital Repository (University of North Carolina at Chapel Hill)23 citationsDOIOpen Access PDF
Abstract
Infants born at 34 to 36 weeks’ gestation (late preterm) have greater risks of adverse respiratory and other outcomes, than those born at 37 weeks gestation or later. It is not known whether betamethasone administered to women at risk for late preterm delivery decreases risks of neonatal morbidities.
Topics & Concepts
BetamethasonePreterm deliveryObstetricsMedicinePregnancyInternal medicineGestationGeneticsBiologyNeonatal Respiratory Health ResearchInfant Development and Preterm CarePreterm Birth and Chorioamnionitis